Tetrahidroimidazol [1,2-a] pyrazines and tetrahidrotriazol [4,3-a] pyrazines as Dipeptidyl peptidase inhibitors useful for the Treatment or prevention of Diabetes

• 收藏
• 分享

专利权人:

Merck Sharp & Dohme Corp.;Merck Sharp & Dohme Corp

发明人:

申请号：

NO2020007

公开号：

NO2020007I1

申请日:

2020.03.19

申请国别(地区):

NO

年份:

2020

代理人:

摘要：

The present invention is directed to pharmaceutical compositions comprising compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and the use of these compositions in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/